Orfadin and haemoglobin decreased Patient Reports February 09, 2010

Orfadin Side Effects Report #5269487-9
Orfadin side effect was reported by a Physician from FRANCE on Feb 23, 2007. Male patient was diagnosed with tyrosinaemia and was treated with Orfadin. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenia, purpura, pyrexia, thrombocytopenia, white blood cell count increased. Orfadin dosage: 0.5 MG/KG TWICE DAILY ORAL. During the same period patient was treated with LASIX, ALDACTONE, PHOSPHORE, CALCIUM SUPP, DOLIPRANE. Patient recovered.

Orfadin Side Effects Report #5081655-8
Orfadin side effect was reported by a Consumer or non-health professional from FRANCE on July 21, 2006. Male patient was diagnosed with tyrosinaemia and was treated with Orfadin. After drug was administered, patient experienced the following side effects: ascites, haemoglobin decreased, neutropenia, purpura, pyrexia, thrombocytopenia. Orfadin dosage: 0.5 MG/KG TWICE DAILY ORAL. During the same period patient was treated with LASILIX, ALDACTONE, PHOSPHORE, CALCIUM SUPP, DOLIPRANE. Patient recovered.

Orfadin Side Effects Report #5874629-8
Orfadin side effect was reported by a Consumer or non-health professional from on Aug 15, 2008. Male patient, weighting 24.25 lb, was diagnosed with tyrosinaemia and was treated with Orfadin. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hepatic failure, liver transplant , lymphoma , no therapeutic response, renal failure. Orfadin dosage: unknown. Patient was hospitalized. Patient recovered.

Orfadin Side Effects Report #4755113-1
Orfadin side effect was reported by a Physician from FRANCE on Aug 10, 2005. Male patient, weighting 1.00 lb, was diagnosed with tyrosinaemia and was treated with Orfadin. After drug was administered, patient experienced the following side effects: ascites, haemoglobin decreased, neutropenia, pyrexia, thrombocytopenia. Orfadin dosage: 0.5 MG/KG TWICE DAILY ORAL. During the same period patient was treated with LASILIX, ALDACTONE, PHOSPHORE, DOLIPRANE. Patient recovered.